Position in AVIR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,260,080
-$1,015,152 QoQ
Shares Held
1,131,200
-3.0% QoQ
Ownership
1.41%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#12
of 124 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,579,858 across 312 Biotechnology names. AVIR ranks #82 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in AVIR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,260,080 | 1,131,200 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $6,275,232 | 1,166,400 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,242,945 | 1,188,500 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,560,910 | 1,227,900 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,442,760 | 1,234,100 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,822,416 | 1,278,400 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,075,610 | 1,216,600 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,043,785 | 1,207,100 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,778,365 | 1,141,500 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $4,538,536 | 1,123,400 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,563,724 | 1,496,303 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,063,623 | 1,354,541 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,099,048 | 1,363,382 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,437,795 | 727,700 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,985,086 | 620,600 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,399,206 | 597,400 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,707,300 | 663,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $8,411,300 | 1,165,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,549,952 | 620,800 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $792,356 | 22,600 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||